Russia Oncology Drugs market was valued at US$ 2.82 billion in 2024 and is projected to reach US$ 4.28 billion by 2030, at a CAGR of 7.2% during the forecast period 2024-2030. Pharmaceuticals specifically designed for the diagnosis, treatment, and prevention of various types of cancer. Strong growth driven by increasing cancer prevalence and advancements in targeted therapies. Rising adoption of..
